2170 related articles for article (PubMed ID: 15107948)
1. The curability of breast cancer and the treatment of advanced disease.
Guarneri V; Conte PF
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
[TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
4. Current and future status of adjuvant therapy for breast cancer.
Coleman RE
Cancer; 2003 Feb; 97(3 Suppl):880-6. PubMed ID: 12548590
[TBL] [Abstract][Full Text] [Related]
5. A systematic overview of chemotherapy effects in breast cancer.
Bergh J; Jönsson PE; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
[TBL] [Abstract][Full Text] [Related]
7. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet; 2005 May 14-20; 365(9472):1687-717. PubMed ID: 15894097
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy of early stage breast cancer].
Boér K
Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
[TBL] [Abstract][Full Text] [Related]
9. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
10. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
Buzdar AU
Oncologist; 2003; 8(4):335-41. PubMed ID: 12897330
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer in limited-resource countries: treatment and allocation of resources.
Eniu A; Carlson RW; Aziz Z; Bines J; Hortobágyi GN; Bese NS; Love RR; Vikram B; Kurkure A; Anderson BO;
Breast J; 2006; 12 Suppl 1():S38-53. PubMed ID: 16430398
[TBL] [Abstract][Full Text] [Related]
12. [Metastatic breast cancer: what are the objectives?].
Salvini P; Ripa C; Ginanni V
Tumori; 2000; 86(5 Suppl 1):S22-8. PubMed ID: 11195289
[TBL] [Abstract][Full Text] [Related]
13. Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
Freedman OC; Verma S; Clemons MJ
Cancer Treat Rev; 2005 Feb; 31(1):1-17. PubMed ID: 15707700
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.
Colozza M; de Azambuja E; Cardoso F; Bernard C; Piccart MJ
Oncologist; 2006 Feb; 11(2):111-25. PubMed ID: 16476832
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of metastatic breast carcinoma].
Puglisi F; Sobrero A
Ann Ital Chir; 1999; 70(3):377-89. PubMed ID: 10466241
[TBL] [Abstract][Full Text] [Related]
16. The choice of systemic adjuvant therapy in receptor-positive early breast cancer.
Dellapasqua S; Castiglione-Gertsch M
Eur J Cancer; 2005 Feb; 41(3):357-64. PubMed ID: 15691634
[TBL] [Abstract][Full Text] [Related]
17. European oncologists' preferences for the management of breast cancer: case presentations and expert commentary.
Anderssona M; Awadab A; Barrett-Leec P; Ellisd P; Hupperetse P; Jackischf C; Kubistag E; Lückh HJ; Monnerati C; Nitzj U; Untchl M
Breast; 2008 Feb; 17 Suppl 2():S1-S12. PubMed ID: 18439963
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer.
Shenkier T; Weir L; Levine M; Olivotto I; Whelan T; Reyno L;
CMAJ; 2004 Mar; 170(6):983-94. PubMed ID: 15023926
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy of primary breast cancer: a review of key findings from the 7th international conference, St. Gallen, February 2001.
Aapro MS
Oncologist; 2001; 6(4):376-85. PubMed ID: 11524557
[TBL] [Abstract][Full Text] [Related]
20. Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
Gradishar WJ
Oncology; 2005; 69(1):1-9. PubMed ID: 16088229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
